Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC44798 | ARV-110 Featured |
ARV-110 is an orally active, specific androgen receptor (AR) PROTAC degrader. ARV-110 promotes ubiquitination and degradation of AR. ARV-110 can be used for the research of prostate cancer.
More description
|
![]() |
DC10993 | RD162 Featured |
RD162 is a second-generation, orally available antiandrogen that binds to androgen receptor (AR) with IC50 of 30.9 nM.
More description
|
![]() |
DC9738 | GSK2881078 Featured |
GSK-2881078 is an orally active and nonsteroidal selective androgen receptor modulator (SARM) which act as partial AR agonists in androgenic tissues while mainly as complete AR agonists in synthetic metabolic tissues,induces AR-mediated transcriptional activation in PC3(AR)2 cells (EC50 = 3.99 nM) and the effect can be inhibited by the non-steroidal AR antagonist Bicalutamide. GSK-2881078 can be used in research of muscle weakness and cachexia associated with both chronic and acute illness.
More description
|
![]() |
DC8122 | Andarine (GTX-007,S-4) Featured |
GTx-007 (S-4) is an orally active and selective nonsteroidal androgen receptor (AR) modulator (SARM) and a partial agonist, with Ki of 4 nM. GTx-007 (S-4) is identified as SARMs with potent and tissue-selective in vivo pharmacological activity.
More description
|
![]() |
DC7633 | Ligandrol (VK5211, LGD-4033) Featured |
Ligandrol (LGD-4033) is a novel nonsteroidal, oral SARM that binds to androgen receptor with high affinity (Ki of 1 nM) and selectivity.
More description
|
![]() |
DC8248 | Ostarine(MK-2286) Featured |
Ostarine (MK-2866) is a selective androgen receptor modulator (SARMs) that regulates cardiomyocyte function, improves bone healing, regulates uterine function, and influences muscle tissue metabolism.
More description
|
![]() |
DC10811 | S23 Featured |
S23 is a novel Selective Androgen Receptor Modulator(SARM)
More description
|
![]() |
DC10812 | ACP-105 Featured |
ACP-105 is a novel non-steroidal SARM (Selective Androgen Receptor Modulator).
More description
|
![]() |
DC47094 | MK-3984 Featured |
MK-3984 is a selective androgen receptor modulator (SARM). MK-3984 can be used for the research of muscle wasting associated with cancer.
More description
|
![]() |
DC74595 | Deutenzalutamide |
Deutenzalutamide (HC-1119, MDV3100) is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells. It can be used in a treatment of advanced prostate cancer.
More description
|
![]() |
DC73807 | UT-215 |
UT-215 (UT215) is a small-molecule selective androgen receptor (AR) irreversible covalent antagonist, covalently and selectively bind to C406 and C327 in the AF-1 region of AR.
More description
|
![]() |
DC73806 | UT-105 |
UT-105 is a small-molecule, irreversible, selective androgen receptor (AR) degrader (SARD) and irreversible inhibitor, binds to AR N-terminal domain (NTD) and inhibits both the AR and AR splice variants (AR-SVs).
More description
|
![]() |
DC73805 | SC428 |
SC428 (SC-428) is a small molecule androgen receptor (AR) signaling inhibitor, directly binds to the AR N-terminal domain (NTD) and exhibits pan-AR inhibitory effect.
More description
|
![]() |
DC73803 | M17-B15 |
M17-B15 is a potent, specific small molecule inhibitor of androgen receptor (AR) targeting the dimer interface pocket (DIP), inhibits AR transcriptional inhibition with IC50 of 0.03 uM.
More description
|
![]() |
DC73802 | JJ-450 |
JJ-450 is a novel analogue of IMTPPE and direct and specific inhibitor of androgen receptor (AR) transcriptional activity, blocks AR recruitment to androgen-responsive elements and suppresses AR target gene expression.
More description
|
![]() |
DC73801 | Faznolutamide |
Faznolutamide is a potent, selective androgen receptor (AR) antagonist.
More description
|
![]() |
DC73800 | ET516 |
ET516 is a potent androgen receptor liquid-liquid phase separation (AR LLPS) inhibitor, specifically disrupts AR condensates, effectively suppresses AR transcriptional activity and inhibits the proliferation and tumor growth of prostate cancer cells expre
More description
|
![]() |
DC72759 | RLA-5331 |
RLA-5331 is an iron activator containing anti-androgen. RLA-5331 has anti-proliferative activity on metastatic castrated tolerant prostate cancer (mCRPC) cell line and can stably exist in vivo.
More description
|
![]() |
DC72758 | Gumelutamide |
Gumelutamide is a tetrahydropyridopyrimidine compound, acting as an antiandrogen, antineoplastic agent. Gumelutamide is an androgen antagonist.
More description
|
![]() |
DC4163 | RU58841 Featured |
RU58841 is a nonsteroidal anti-androgen with potency (IC50 = 100 nM, Ka = 1.1 nM) comparable to hydroxyflutamide.
More description
|
![]() |
DC8690 | ORM-15341(Ketodarolutamide) Featured |
ORM-15341 is a potent and full antagonist for human AR (hAR) with IC50 values of 38 nM as shown by transactivation assays in AR-HEK293 cells stably expressing full-length hAR and an androgen-responsive luciferase reporter gene construct.
More description
|
![]() |
DC8700 | ODM-201(Darolutamide) Featured |
ODM-201 is a potent and full antagonists for human AR (hAR) with IC50 values of 26 nM by transactivation assays in AR-HEK293 cells.
More description
|
![]() |
DC5069 | Enzalutamide (MDV3100) Featured |
MDV3100 is an androgen-receptor (AR) antagonist with IC50 of 36 nM.
More description
|
![]() |
DC8856 | EPI-001 Featured |
EPI-001 is an androgen receptor N-terminal domain antagonist with IC50 of ∼6 μM and a selective PPAR-gamma modulator
More description
|
![]() |
DC42525 | (R)-Bicalutamide |
(R)-Bicalutamide is the (R)-enantiomer of Bicalutamide. (R)-Bicalutamide is an androgen receptor (AR) antagonist, with an antineoplastic activity. (R)-Bicalutamide is widely used for the research of prostate cancer.
More description
|
![]() |
DC42465 | ABM-14 |
ABM-14 is a ligand for targeting androgen receptor (AR) for PROTAC. ABM-14 binds to a ligand for VHL via linker to form ARCC-4 to degrade AR。
More description
|
![]() |
DC72105 | EPI-7170 |
EPI-7170, a ralaniten analogue, is a potent androgen receptor N-terminal structural domain antagonist that blocks the transcriptional activity of full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 has antitumor effects against enzalutamide resistant castration-resistant prostate cancer (CRPC).
More description
|
![]() |
DC72104 | ARD-69 |
ARD-69 (compound 34) is a potent PROTAC androgen receptor degrader. ARD-69 induces degradation of androgen receptor (AR) protein in AR-positive prostate cancer cell lines. ARD-69 suppresses AR-regulated gene expression.
More description
|
![]() |
DC71641 | Adrenocorticotropic hormone |
Adrenocorticotropic hormone (ACTH) is a polypeptide tropic hormone produced by the anterior pituitary gland. Adrenocorticotropic hormone regulates cortisol and androgen production.
More description
|
![]() |
DC9657 | RAD140 Featured |
RAD140 is a potent, orally bioavailable, nonsteroidal selective androgen receptor modulator (SARM).
More description
|
![]() |